Literature DB >> 23517305

Proton bridging in the interactions of thrombin with hirudin and its mimics.

Ildiko M Kovach1, Lazaros Kakalis, Frank Jordan, Daoning Zhang.   

Abstract

Thrombin is the pivotal serine protease enzyme in the blood cascade system and thus a target of drug design for control of its activity. The most efficient nonphysiologic inhibitor of thrombin is hirudin, a naturally occurring small protein. Hirudin and its synthetic mimics employ a range of hydrogen bonding, salt bridging, and hydrophobic interactions with thrombin to achieve tight binding with K(i) values in the nano- to femtomolar range. The one-dimensional (1)H nuclear magnetic resonance spectrum recorded at 600 MHz reveals a resonance 15.33 ppm downfield from silanes in complexes between human α-thrombin and r-hirudin in pH 5.6-8.8 buffers and between 5 and 35 °C. There is also a resonance between 15.17 and 15.54 ppm seen in complexes of human α-thrombin with hirunorm IV, hirunorm V, an Nα(Me)Arg peptide, RGD-hirudin, and Nα-2-naphthylsulfonyl-glycyl-DL-4-amidinophenylalanyl-piperidide acetate salt (NAPAP), while there is no such low-field resonance observed in a complex of porcine trypsin and NAPAP. The chemical shifts suggest that these resonances represent H-bonded environments. H-Donor-acceptor distances in the corresponding H-bonds are estimated to be <2.7 Å. Addition of Phe-Pro-Arg-chloromethylketone (PPACK) to a complex of human α-thrombin with r-hirudin results in an additional signal at 18.03 ppm, which is 0.10 ppm upfield from the observed signal [Kovach, I. M., et al. (2009) Biochemistry 48, 7296-7304] for thrombin covalently modified with PPACK. In contrast, the peak at 15.33 ppm remains unchanged. The fractionation factors for the thrombin-hirudin complexes are near 1.0 within 20% error. The most likely site of the short H-bond in complexes of thrombin with the hirudin family of inhibitors is in the hydrophobic patch of the C-terminus of hirudin where Glu(57') and Glu(58') are embedded and interact with Arg(75) and Arg(77) and their solvate water (on thrombin). Glu(57') and Glu(58') present in the hirudin family of inhibitors make up a key binding epitope of fibrinogen, thrombin's prime substrate, which lends substantial interest to the short hydrogen bond as a binding element at the fibrinogen recognition site.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23517305      PMCID: PMC3750058          DOI: 10.1021/bi301625a

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  75 in total

1.  From natural to synthetic multisite thrombin inhibitors.

Authors:  A Lombardi; G De Simone; S Galdiero; N Staiano; F Nastri; V Pavone
Journal:  Biopolymers       Date:  1999       Impact factor: 2.505

2.  A new concept for the mechanism of action of chymotrypsin: the role of the low-barrier hydrogen bond.

Authors:  C S Cassidy; J Lin; P A Frey
Journal:  Biochemistry       Date:  1997-04-15       Impact factor: 3.162

3.  High resolution nuclear magnetic resonance studies of the active site of chymotrypsin. II. Polarization of histidine 57 by substrate analogues and competitive inhibitors.

Authors:  G Robillard; R G Shulman
Journal:  J Mol Biol       Date:  1974-07-05       Impact factor: 5.469

4.  A low-barrier hydrogen bond in subtilisin: 1H and 15N NMR studies with peptidyl trifluoromethyl ketones.

Authors:  C J Halkides; Y Q Wu; C J Murray
Journal:  Biochemistry       Date:  1996-12-10       Impact factor: 3.162

5.  Linkage at steady state: allosteric transitions of thrombin.

Authors:  E Di Cera; Q D Dang; Y Ayala; A Vindigni
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

6.  Low-barrier hydrogen bonds and enzymic catalysis.

Authors:  W W Cleland; M M Kreevoy
Journal:  Science       Date:  1994-06-24       Impact factor: 47.728

7.  Fractionation factors and activation energies for exchange of the low barrier hydrogen bonding proton in peptidyl trifluoromethyl ketone complexes of chymotrypsin.

Authors:  J Lin; W M Westler; W W Cleland; J L Markley; P A Frey
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

8.  Proton bridging in the interactions of thrombin with small inhibitors.

Authors:  Ildiko M Kovach; Paul Kelley; Carol Eddy; Frank Jordan; Ahmet Baykal
Journal:  Biochemistry       Date:  2009-08-04       Impact factor: 3.162

9.  The structure of a complex of recombinant hirudin and human alpha-thrombin.

Authors:  T J Rydel; K G Ravichandran; A Tulinsky; W Bode; R Huber; C Roitsch; J W Fenton
Journal:  Science       Date:  1990-07-20       Impact factor: 47.728

10.  Crystal structure of wild-type human thrombin in the Na+-free state.

Authors:  Daniel J D Johnson; Ty E Adams; Wei Li; James A Huntington
Journal:  Biochem J       Date:  2005-11-15       Impact factor: 3.857

View more
  1 in total

Review 1.  Proton Bridging in Catalysis by and Inhibition of Serine Proteases of the Blood Cascade System.

Authors:  Ildiko M Kovach
Journal:  Life (Basel)       Date:  2021-04-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.